Adventrx Pharmaceuticals (ANX +12%) pops after saying it's arranged a meeting with the FDA to...

|By:, SA News Editor

Adventrx Pharmaceuticals (ANX +12%) pops after saying it's arranged a meeting with the FDA to discuss the approval of three late-stage pipeline products: ANX-514, ANX-188 and Exelbine.